Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 01.02.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
01.02.23CLIQ Digital - Progress made against KPIs884CLIQ Digital's FY22 update showed strong year-on-year growth across all KPIs, as it continues to roll out its subscription-based bundled-content streaming services. The results were broadly in line...
► Artikel lesen
01.02.23Endeavour Mining - Meeting guidance for 10th consecutive year847In preparation for FY22 results on 9 March, Endeavour has released preliminary operational results. Q422 saw a 4% increase in gold production, totalling 355koz, showing a strong close to the year, whereas...
► Artikel lesen
01.02.23Notice - Termination of coverage - Termination of coverage413Edison Investment Research is terminating coverage on Vivesto (VIVE), Diurnal Group (DNL), Palace Capital (PCA), Primary Health Properties (PHP), Silver One Resources (SVE), Induction Healthcare (INHC)...
► Artikel lesen
01.02.23Filtronic - Expansion of presence in satcom market405Filtronic has announced a contract win worth more than £2.0m with a new customer in the satellite communications equipment market, demonstrating its ability to diversify outside its three core sectors....
► Artikel lesen
01.02.23Kazia Therapeutics - Reinvestment period with increased R&D focus759Kazia Therapeutics has released its Q223 activity report and provided a business update for the quarter. Q2 was marked by increased preclinical efforts towards exploring the applicability and efficacy...
► Artikel lesen
01.02.23Incannex Healthcare - Pipeline advancement to support growth plan375Incannex Healthcare's Q223 cash flow report provided the period's key operational highlights. Notable activities include the start of a bioavailability and bioequivalence (BA/BE) study for its lead...
► Artikel lesen